Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

LBBB Remains Problematic 1 Year Post-TAVI: TVT Registry

Yael L. Maxwell

January 07, 2026

News Daily News

People Age 90-Plus Do Fine With EVAR

Todd Neale

April 13, 2021

News Daily News

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

Todd Neale

March 08, 2021

News Daily News

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

Yael L. Maxwell

January 02, 2019

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

L.A. McKeown

May 11, 2018

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

News Daily News

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

L.A. McKeown

December 13, 2016

News Industry News

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

October 20, 2015

News Industry News

Medtronic touts 5-year Endurant AAA stent data

June 23, 2015

News Daily News

Ambulatory EVAR an Option for One-Third of AAA Patients

Yael L. Maxwell

August 30, 2013

News Daily News

Early Mortality Benefit of EVAR vs. Open AAA Repair Holds up Long-term

L.A. McKeown

April 18, 2012

Advertisement

LBBB Remains Problematic 1 Year Post-TAVI: TVT Registry

People Age 90-Plus Do Fine With EVAR

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

EVAR Outcomes Equivalent Between Men and Women, Registries Show

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

Medtronic touts 5-year Endurant AAA stent data

Ambulatory EVAR an Option for One-Third of AAA Patients

Early Mortality Benefit of EVAR vs. Open AAA Repair Holds up Long-term

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content